Chemical Compound

Sacituzumab govitecan

CAS Registry Number 1491917-83-9
Sacituzumab govitecan chemical structure
Primary Record

Sacituzumab govitecan

In stock
2,379 g
Purity
99.2 %
CAS
1491917-83-9

Compound Identifiers & Properties

CAS
1491917-83-9
PubChem CID
91668186
SMILES
CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)OC(=O)OCC5=CC=C(C=C5)NC(=O)[C@H](CCCCN)NC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCN6C=C(N=N6)CNC(=O)C7CCC(CC7)CN8C(=O)CC(C8=O)SC[C@@H](C(=O)O)N)C2=NC9=C1C=C(C=C9)O
Canonical SMILES
CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@@]3(CC)OC(=O)OCc1ccc(NC(=O)[C@H](CCCCN)NC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCn2cc(CNC(=O)C3CCC(CN4C(=O)CC(SC[C@H](N)C(=O)O)C4=O)CC3)nn2)cc1

Names & Synonyms

  • Sacituzumab govitecan
  • Sacituzumab
  • satralizumab
  • Trodelvy
  • Satralizumab linker
  • hRS7-SN38
  • SacituzumabGovitecan
  • sacituzumab-govitecan
  • UNII-M9BYU8XDQ6
  • M9BYU8XDQ6
  • IMMU-132
  • Sacituzumab govitecan [USAN]
  • hRS 7SN38
  • Antibiotic KA 5905
  • sacituzumabum govitecanum
  • RefChem:58300
  • IMMU 132
  • Sacituzumab govitecan-hziy
  • hRS7SN38
  • DA64T2C2IO
  • CYSTEINYL CL2A-SN-38
  • DTXSID401335985
  • orb2702946
  • RS7-SN38
  • Sacituzumab (lyophilized powder)
  • SCHEMBL29407082
  • SN-38 CYSTEINYL CONJUGATE
  • BADC-01603
  • DTXCID601766057
  • EX-A4354
  • GOVITECAN CYSTEINYL CONJUGATE
  • hRS7-SN38 Antibody Drug Conjugate
  • 1491917-83-9
  • BP-50188
  • DA-77702
  • HRS7-SN38-ANTIBODY-DRUG-CONJUGATE
  • F82944
  • 1796566-95-4
  • A1014817
  • 1535963-91-7
  • (2R)-2-amino-3-[1-[[4-[[1-[2-[2-[2-[2-[2-[2-[2-[2-[2-[[2-[2-[[(2S)-6-amino-1-[4-[[(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-19-yl]oxycarbonyloxymethyl]anilino]-1-oxohexan-2-yl]amino]-2-oxoethoxy]acetyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]triazol-4-yl]methylcarbamoyl]cyclohexyl]methyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoic acid
  • 101550-73-6